BioSpace News Archive

Business

EmpiraMed’s CMO Selected to Share His Unique Perspective on Effective Patient Engagement Strategies

Best-in-Class Real World Evidence Metrics Disclosed in New Managed Care Article

October 30, 2018
·
2 min read
Pharm Country

PTC Therapeutics to Participate at Upcoming November 2018 Investor Conference

PTC Therapeutics, Inc. today announced that management will present a company overview at the Credit Suisse 27th Annual Healthcare Conference on Tuesday, November 13th at 10:55 a.m. MST.

October 30, 2018
·
1 min read
Liht Cannabis Corp. taking measures to ensure cannabis quality and yield

Within this news release, the Company will provide our current and prospective shareholders with the steps and measures we will be taking to ensure product quality and cultivation yield.

October 30, 2018
·
9 min read
Job Trends

Positive Accolades Roll in for Sober Up® & For Former Red Bull UK CEO Harry Drnec

Sober Up®, a detox shot made from naturally sourced ingredients that detoxes the body, helps support liver health and helps tackle the cause of a hangover, is getting the attention of people from all over

October 30, 2018
·
2 min read
BioForest

Talking Rain® Beverage Co. Strengthens Corporate Social Responsibility Commitments in October

Talking Rain® Beverage Company, the makers of zero sugar Sparkling Ice®, is proud to share today a range of corporate social responsibly initiatives that have little to do with the company’s success, and everything to do with its heart.

October 30, 2018
·
4 min read
FDA

FDA Grants Breakthrough Therapy Designation (BTD) for UroGen Pharma’s UGN-101 for the Treatment of Patients with Low-Grade Upper Tract Urothelial Cancer (LG UTUC)

UGN-101 Joins Select Group of Urologic Oncology Product Candidates to Receive BTD

October 30, 2018
·
7 min read
Business

Second Sight to Discuss Third Quarter 2018 Financial Results on November 7, 2018 Conference Call

Second Sight Medical Products, Inc. (NASDAQ: EYES), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision to blind individuals, will release its 2018 third quarter financial results on Wednesday, November 7, 2018

October 30, 2018
·
6 min read
Drug Development

Pharm-Olam Conducts Pivotal Orphan Disease Trial, Leads to First Therapeutic Approved for the Treatment for Acquired Thrombotic Thrombocytopenic Purpura

Pharm-Olam is proud to have contributed to the execution and completion of its pivotal Phase III study.

October 30, 2018
·
2 min read
Business

Sentry Data Systems appoints Ron Linares as Chief Financial Officer

Ron will be responsible for continuing the company’s history of financial success and sound financial decision making.

October 30, 2018
·
2 min read
Business

ProCARE Portal Innovates Physician Compensation Market

SaaS Platform Making Provider Compensation Easy, Automated, and Accessible

October 30, 2018
·
2 min read